Inventor · disambiguated record
Cyrille Lescop
Also filed as: LESCOP CYRILLE
14 granted patents·5 pending applications·67 citations·filing 2004–2022
91Inventor score
Files withBOLLI MARTIN8IDORSIA PHARMACEUTICALS LTD6SANTHERA PHARMACEUTICALS CH3ACTELION PHARMACEUTICALS LTD1HERZNER HOLGER1
Top patents by PatentIndex Score
19 records- 0191US10385043B2Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diolIDORSIA PHARMACEUTICALS LTD·Filed 2016·Granted Aug 20, 2019·4 cites·9 claims
- 0288US8299086B2Pyrimidine derivativesBOLLI MARTIN·Filed 2008·Granted Oct 30, 2012·14 cites·13 claims
- 0387US8148410B2Thiophene derivatives as agonists of S1P1/EDG1BOLLI MARTIN·Filed 2008·Granted Apr 3, 2012·11 cites·15 claims
- 0486US11390615B2Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxIDORSIA PHARMACEUTICALS LTD·Filed 2020·Granted Jul 19, 2022·1 cites·19 claims
- 0585US10836754B2Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diolIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Nov 17, 2020·1 cites·33 claims
- 0683US8598208B2Pyridine derivatives as S1P1/EDG1 receptor modulatorsBOLLI MARTIN·Filed 2008·Granted Dec 3, 2013·6 cites·8 claims
- 0783US8575200B2Pyridin-2-yl derivatives as immunomodulating agentsBOLLI MARTIN·Filed 2009·Granted Nov 5, 2013·6 cites·14 claims
- 0883US8410151B2Aminomethyl benzene derivativesBOLLI MARTIN·Filed 2009·Granted Apr 2, 2013·6 cites·10 claims
- 0982US12344597B2Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosisIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Jul 1, 2025·2 cites·21 claims
- 1082US8658675B2Pyridin-4-yl derivativesBOLLI MARTIN·Filed 2010·Granted Feb 25, 2014·7 cites·45 claims
- 1180US9617250B2Pyridin-4-yl derivativesACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Apr 11, 2017·4 cites·11 claims
- 1279US11834443B2Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diolIDORSIA PHARMACEUTICALS LTD·Filed 2022·Granted Dec 5, 2023·0 cites·26 claims
- 1379US9133179B22-methoxy-pyridin-4-yl-derivativesBOLLI MARTIN·Filed 2012·Granted Sep 15, 2015·5 cites·23 claims
- 1451US12479820B2Pyridin-3-yl derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2020·Granted Nov 25, 2025·0 cites·17 claims
- 1551US2011028448A1Pyridine compoundsBOLLI MARTIN·Filed 2009·Application pending·0 cites
- 1639US2011086836A1Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor ModulatorsSANTHERA PHARMACEUTICALS CH·Filed 2007·Application pending·0 cites
- 1733US2007293486A1Alpha-Keto Carbonyl Calpain InhibitorsSANTHERA PHARMACEUTICALS CH·Filed 2005·Application pending·0 cites
- 1833US2006258598A1Alpha-keto carbonyl calpain inhibitorsHERZNER HOLGER·Filed 2004·Application pending·0 cites
- 1933US2008058324A1Alpha-Keto Carbonyl Calpain InhibitorsSANTHERA PHARMACEUTICALS CH·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cyrille Lescop files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →